NCT00004786

Who might be able to join this trial:

• You have been diagnosed with Raynaud's phenomenon (a condition causing reduced blood flow to the fingers/toes) that is caused by systemic sclerosis (a connective tissue disease), confirmed using standard medical guidelines
• You experience at least 6 Raynaud's attacks per week
• You have not taken part in a previous study using oral iloprost
• It has been at least 4 weeks since you took part in any other study involving an experimental drug
• It has been at least 2 months since you last used a type of medication called prostanoids
• It has been at least 12 months since you had a nerve-cutting procedure (sympathectomy) on your upper arm or hand
• Any ongoing treatment you receive for systemic sclerosis can continue during the trial (though current Raynaud's treatments would need to stop when you join)

Who may not be able to join:

• You have a disorder affecting your blood platelets (cells that help with clotting)
• You have a condition that causes unusual or excessive bleeding
• Your kidneys are not filtering blood well enough (below a certain level, confirmed with trial site)
• You have unstable chest pain (unstable angina)
• You have had a stroke, a mini-stroke (transient ischemic attack), or a heart attack within the last 3 months
• You currently have active cancer or another serious uncontrolled illness
• You currently have a problem with alcohol or drug misuse
• You have a mental health condition that would make it difficult to follow the trial's instructions
• You are pregnant or breastfeeding
• If you are able to become pregnant, you must have a negative pregnancy test and be using reliable contraception

Important: Always verify eligibility with the trial site directly before applying.